Cargando…

Biobanked Glioblastoma Patient-Derived Organoids as a Precision Medicine Model to Study Inhibition of Invasion

Glioblastoma (GBM) is highly resistant to treatment and invasion into the surrounding brain is a cancer hallmark that leads to recurrence despite surgical resection. With the emergence of precision medicine, patient-derived 3D systems are considered potentially robust GBM preclinical models. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Darrigues, Emilie, Zhao, Edward H., De Loose, Annick, Lee, Madison P., Borrelli, Michael J., Eoff, Robert L., Galileo, Deni S., Penthala, Narsimha R., Crooks, Peter A., Rodriguez, Analiz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509225/ https://www.ncbi.nlm.nih.gov/pubmed/34639060 http://dx.doi.org/10.3390/ijms221910720

Ejemplares similares

Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon
por: Darrigues, Emilie, et al.
Publicado: (2021)

323 Generation of a functional precision medicine pipeline which combines comparative transcriptomics and tumor organoid modeling to identify bespoke treatment strategies for glioblastoma
por: Reed, Megan R., et al.
Publicado: (2022)

A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for Glioblastoma
por: Reed, Megan R., et al.
Publicado: (2021)

Genomic and Transcriptomic Profiling of Brain Metastases
por: Wardell, Christopher P., et al.
Publicado: (2021)

Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness
por: Pace, Karma R., et al.
Publicado: (2019)

Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
por: Zhou, Zilong, et al.
Publicado: (2021)

Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer
por: Urbaniak, Alicja, et al.
Publicado: (2022)

rac-5-Bromo-N-benzylisatincreatinine ethanol monosolvate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

rac-N-Benzylisatincreatinine (unknown solvate)
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

(Z)-3-(1H-Indol-3-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

(Z)-3-(1-Benzofuran-2-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

13-(Imidazol-1-yl)-11,13-dihydromelampomagnolide B monohydrate
por: Janganati, Venumadhav, et al.
Publicado: (2013)

Crystal structure of (E)-13-(pyrimidin-5-yl)parthenolide
por: Bommagani, Shobanbabu, et al.
Publicado: (2015)

317 Omics based analysis to identify novel markers of TMZ response in Glioblastoma Multiforme
por: Reed, Megan R., et al.
Publicado: (2023)

rac-(Z)-Methyl 1-benzyl-3-[(3-hydroxyquinuclidin-2-ylidene)methyl]-1H-indole-6-carboxylate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion
por: Li, Yupei, et al.
Publicado: (2010)

(Z)-Methyl 4-[3-(3-oxoquinuclidin-2-ylidenemethyl)-1H-indol-1-ylmethyl]benzoate
por: Reddy, Thirupathi Reddy Yerram, et al.
Publicado: (2008)

(Z)-4-[3-(3-Oxoquinuclidin-2-ylidenemethyl)-1H-indol-1-ylmethyl]benzonitrile
por: Reddy, Thirupathi Reddy Yerram, et al.
Publicado: (2008)

(Z)-4-[3-(2,5-Dioxoimidazolidin-4-ylidenemethyl)-1H-indol-1-ylmethyl]benzonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2008)

(Z)-Methyl 4-({3-[(2,5-dioxoimidazolidin-4-ylidene)methyl]-1H-indol-1-yl}methyl)benzoate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2008)

3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-3-hydroxyindolin-2-one monohydrate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2009)

rac-2-(2-Amino-4-oxo-4,5-dihydro-1,3-thiazol-5-yl)-2-hydroxyindane-1,3-dione
por: Penthala, Narsimha Reddy, et al.
Publicado: (2009)

3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-5-fluoro-3-hydroxy-1-methylindolin-2-one methanol hemisolvate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2009)

3-(2-Amino-1-methyl-4-oxo-4,5-dihydro-1H-imidazol-5-yl)-3-hydroxy-1-phenylindolin-2-one ethanol solvate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2009)

(2Z,3E)-2-{[1-(4-Chlorobenzyl)-1H-indol-3-yl]methylidene}quinuclidin-3-one oxime
por: Penthala, Narsimha Reddy, et al.
Publicado: (2011)

13-(N,N-Dimethylamino)micheliolide 0.08-hydrate
por: Bommagani, Shobanbabu, et al.
Publicado: (2013)

(E)-13-(2-Bromophenyl)micheliolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2014)

Crystal structure of (E)-13-{4-[(Z)-2-cyano-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl}parthenolide methanol hemisolvate
por: Penthala, Narsimha Reddy, et al.
Publicado: (2014)

Crystal structures of (Z)-5-[2-(benzo[b]thiophen-2-yl)-1-(3,5-dimethoxyphenyl)ethenyl]-1H-tetrazole and (Z)-5-[2-(benzo[b]thiophen-3-yl)-1-(3,4,5-trimethoxyphenyl)ethenyl]-1H-tetrazole
por: Penthala, Narsimha Reddy, et al.
Publicado: (2016)

Biobanking—Budgets and the Role of Pathology Biobanks in Precision Medicine
por: Andry, Chris, et al.
Publicado: (2017)

An organoids biobank for recapitulating tumor heterogeneity and personalized medicine
por: Yang, Hui, et al.
Publicado: (2020)

(E)-13-(4-Aminophenyl)parthenolide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2013)

Monosuccinate ester of melampomagnolide B
por: Janganati, Venumadhav, et al.
Publicado: (2014)

Comparison of crystal structures of 4-(benzo[b]thiophen-2-yl)-5-(3,4,5-trimethoxyphenyl)-2H-1,2,3-triazole and 4-(benzo[b]thiophen-2-yl)-2-methyl-5-(3,4,5-trimethoxyphenyl)-2H-1,2,3-triazole
por: Penthala, Narsimha Reddy, et al.
Publicado: (2014)

Crystal structure of 4,5-bis(3,4,5-trimethoxyphenyl)-2H-1,2,3-triazole methanol monosolvate
por: Madadi, Nikhil Reddy, et al.
Publicado: (2014)

Comparison of the crystal structures of 4,4′-bis[3-(4-methylpiperidin-1-yl)prop-1-yn-1-yl]-1,1′-biphenyl and 4,4′-bis[3-(2,2,6,6-tetramethylpiperidin-1-yl)prop-1-yn-1-yl]-1,1′-biphenyl
por: Wan, Anqi, et al.
Publicado: (2015)

Comparison crystal structure conformations of two structurally related biphenyl analogues: 4,4′-bis[3-(pyrrolidin-1-yl)prop-1-yn-1-yl]-1,1′-biphenyl and 4,4′-bis{3-[(S)-2-methylpyrrolidin-1-yl]prop-1-yn-1-yl}-1,1′-biphenyl
por: Wan, Anqi, et al.
Publicado: (2015)

Organoid biobanking, autonomy and the limits of consent
por: Lewis, Jonathan, et al.
Publicado: (2022)

cis-1-Benzylpyrrolidine-2,5-dicarbonitrile
por: Ponugoti, Purushothama Rao, et al.
Publicado: (2011)

(E,E)-1-Methyl-2,6-distyrylpyridinium iodide
por: Penthala, Narsimha Reddy, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_irkdqo0l24dbvoe5lmoomvrp0m